scholarly journals Acral Necrosis in a COVID-19-Infected Man Treated with Botulinum Toxin Type A

2021 ◽  
pp. 568-573
Author(s):  
Mette Soelberg Schjødt ◽  
Rikke Bech ◽  
Anne Braae Olesen
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Worst Case ◽  
First Case ◽  
Digital Necrosis ◽  
Acral Necrosis ◽  
Acral Ischemia ◽  
Digital Or

COVID-19 has been associated with acral ischemia and digital necrosis. Standard treatment of acral ischemia and digital or acral necrosis includes ongoing therapy with vasodilators and anticoagulants. However, these treatments are not always efficient to avoid the progression of necroses, which in the worst case can lead to amputation. Here, we report a case in which interdigital Botox<sup>®</sup> (botulinum toxin type A) nerve cord injection stopped the progression of acral necroses arising from an underlying vasculopathy due to COVID-19. Moreover, Botox<sup>®</sup> injection eliminated inflammation in the affected acral area within 2 weeks. This is the first case report to suggest Botox<sup>®</sup> injection as a new and improving treatment for acral necroses due to COVID-19.

scholarly journals A Case of Parotid Gland Fistula After Microtia Reconstruction Successfully Treated With Botulinum Toxin Type A

2021 ◽  
pp. 014556132110383
Author(s):  
Bo Zhang ◽  
Suqi Xu ◽  
Gaofeng Li ◽  
Wei Ding ◽  
Xiren Long ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Parotid Gland ◽  
Wound Dressing ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
First Case ◽  
Accessory Parotid Gland

Parotid gland fistula after microtia reconstruction is relatively rare, with only 3 cases having been reported in the literature. It may be caused by the presence of an accessory parotid gland or surgical damage to parotid gland tissues. The principal treatment is dressing the wound. Here, we report the first case of parotid fistula after microtia reconstruction using a delayed retroauricular flap, which healed following wound dressing and an injection of botulinum toxin type A (CBTXA) into the parotid gland.

First case of anaphylaxis after botulinum toxin type A injection

2017 ◽  
Vol 42 (7) ◽  
pp. 760-762 ◽  
Author(s):  
I. J. Moon ◽  
S. E. Chang ◽  
S. D. Kim
Keyword(s):  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
First Case

Botulinum Toxin Type A Therapy in Chronic Headache Patients

2005 ◽  
Vol 18 (1) ◽  
pp. 29
Author(s):  
Dong Eon Moon ◽  
Young Eun Moon ◽  
Shi Hyeon Kim ◽  
Eun Sung Kim
Keyword(s):  
Botulinum Toxin ◽  
Chronic Headache ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Headache Patients
Sign in / Sign up

Export Citation Format

Share Document